Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: DynaGen

Executive Summary

DynaGen: Acquires Alpharma subsidiary Able Labs, Cambridge, Mass.-based firm announces Aug. 12. DynaGen is paying $550,000 in cash for the business; Able had $2.5 mil. in 1995 revenues and operated at a loss. DynaGen will acquire rights to 10 approved tablet and suppository ANDA products, a 46,000 sq. ft. manufacturing facility in South Plainfield, N.J. and 45 employees. DynaGen plans to establish a multi-source and specialty pharmaceutical division. It is developing NicErase sublingual lobeline for smoking cessation and anticipates the Able acquisition would provide manufacturing for the product. DynaGen will have $9 mil. in cash after the acquisition...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028712

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel